LA
GILD icon

LVW Advisors’s Gilead Sciences GILD Stock Holding History

LVW Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Sell
23,396
-152
-0.6% -$20K 0.26% 55
2026
Q1 		$3.28M Buy
23,548
+1,727
+8% +$242K 0.31% 43
2025
Q4 		$2.68M Buy
21,821
+1,872
+9% +$227K 0.27% 48
2025
Q3 		$2.21M Buy
19,949
+271
+1% +$30.8K 0.23% 58
2025
Q2 		$2.18M Buy
19,678
+1,338
+7% +$142K 0.24% 58
2025
Q1 		$2.05M Sell
18,340
-483
-3% -$49.8K 0.25% 54
2024
Q4 		$1.74M Buy
18,823
+4
+0% +$360 0.21% 71
2024
Q3 		$1.58M Buy
18,819
+1,939
+11% +$148K 0.2% 78
2024
Q2 		$1.16M Sell
16,880
-8,700
-34% -$581K 0.17% 88
2024
Q1 		$1.87M Buy
25,580
+9,223
+56% +$709K 0.32% 53
2023
Q4 		$1.33M Buy
16,357
+5,142
+46% +$400K 0.25% 66
2023
Q3 		$840K Buy
11,215
+5,675
+102% +$437K 0.17% 84
2023
Q2 		$427K Sell
5,540
-396
-7% -$31.6K 0.08% 141
2023
Q1 		$493K Buy
5,936
+498
+9% +$41.2K 0.1% 146
2022
Q4 		$467K Sell
5,438
-11
-0.2% -$871 0.1% 152
2022
Q3 		$336K Buy
5,449
+5
+0.1% +$315 0.08% 164
2022
Q2 		$336K Sell
5,444
-5
-0.1% -$310 0.07% 177
2022
Q1 		$324K Buy
5,449
+42
+0.8% +$2.69K 0.05% 186
2021
Q4 		$393K Sell
5,407
-903
-14% -$62.2K 0.07% 170
2021
Q3 		$441K Hold
6,310
– – 0.08% 170
2021
Q2 		$435K Sell
6,310
-258
-4% -$17.2K 0.08% 159
2021
Q1 		$424K Buy
6,568
+270
+4% +$17.4K 0.08% 161
2020
Q4 		$367K Sell
6,298
-217
-3% -$13.1K 0.07% 146
2020
Q3 		$412K Buy
6,515
+1,996
+44% +$138K 0.09% 119
2020
Q2 		$348K Sell
4,519
-302
-6% -$23.1K 0.08% 128
2020
Q1 		$360K Sell
4,821
-696
-13% -$48.1K 0.1% 103
2019
Q4 		$358K Hold
5,517
– – 0.08% 128
2019
Q3 		$350K Buy
5,517
+1,298
+31% +$84.8K 0.09% 115
2019
Q2 		$285K Buy
+4,219
New +$278K 0.08% 126
2017
Q2 		– Sell
-32,320
Closed -$2.19M – 117
2017
Q1 		$2.19M Buy
32,320
+1,773
+6% +$125K 0.79% 35
2016
Q4 		$2.19M Buy
30,547
+27,955
+1,079% +$2.08M 0.76% 35
2016
Q3 		$205K Buy
2,592
+173
+7% +$14.1K 0.07% 134
2016
Q2 		$202K Sell
2,419
-1,053
-30% -$93.5K 0.08% 126
2016
Q1 		$319K Sell
3,472
-382
-10% -$34.4K 0.1% 105
2015
Q4 		$390K Buy
3,854
+106
+3% +$11K 0.15% 90
2015
Q3 		$368K Buy
3,748
+781
+26% +$86.7K 0.17% 94
2015
Q2 		$347K Buy
2,967
+50
+2% +$5.46K 0.15% 94
2015
Q1 		$286K Buy
2,917
+211
+8% +$21.4K 0.14% 121
2014
Q4 		$255K Buy
+2,706
New +$280K 0.14% 127

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LVW Advisors's GILD Position: Q2 2026 in Review

LVW Advisors reduced its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, selling an estimated $20K and leaving 23,396 shares worth $2.96M. The position accounts for 0.26% of the portfolio, ranked #55.

LVW Advisors first reported a position in GILD in Q4 2014 and has held it in 39 quarters since. The position peaked at $3.28M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LVW Advisors held 23,396 shares of Gilead Sciences worth $2.96M as of Q2 2026.
  • LVW Advisors sold 152 Gilead Sciences shares in Q2 2026, an estimated $20K.
  • Gilead Sciences made up 0.26% of LVW Advisors's portfolio in Q2 2026, its #55 holding.
  • LVW Advisors first reported a position in Gilead Sciences in Q4 2014 and has held it in 39 quarters since.
  • LVW Advisors's Gilead Sciences position peaked at $3.28M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.